Main Changes in Company’s Share Capital | Shares at a Discount | Preference Shares for More Than 20 years | Private Placement, Bonus Shares and GDRs | Alteration of Share Capital | Consolidation and Division of Shares
Category: Pharmaceutical Industry In India
Directors And Their Powers in Accordance with The Companies Act, 2013
Directors And Their Powers | Maximum Number Of Directors | Maximum Number Of Directorship | Composition Of Board | Resignation Of Director | Vacancy Of Office For Not Attending Board Meetings | Disclosures In Board’s Report | Special Resolution
Patent Expirations & Biosimilar Drug Regulations In Pharmaceutical Industry: Regulatory Guidelines in India
Earlier this year, in Feb. 2012, FDA issued draft guidance on biosimilar product development, and The Patient Protection and Affordable Care Act, which was signed into law by President Obama on March 23, 2010, amended the Public Health Service Act to create an abbreviated approval pathway -- under section 351(k) -- for biological products that… Continue reading Patent Expirations & Biosimilar Drug Regulations In Pharmaceutical Industry: Regulatory Guidelines in India
You must be logged in to post a comment.